 |
인쇄하기
취소
|
LG Life Sciences set to commercialize new anti-hepatitis B drug in 2007
LG Life Sciences announced that its own novel anti-hepatitis drug (LB80380) under development will be launched by 2007, as the drug has proven to be effective and safe as a result of foreign trials.
The company presented the clinical IIa results of LB80380 to 2003 U.S. HEP DART congress on December 17.
Recently, the new promising anti-hepatitis agent completed Phase IIa trial in Hong Kon...
The company presented the clinical IIa results of LB80380 to 2003 U.S. HEP DART congress on December 17.
Recently, the new promising anti-hepatitis agent completed Phase IIa trial in Hong Kon...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.